TL-201

N/A

Report date: 2025/01/26 17:54:12

Base Information

Drug NameTL-201
Drug Alias NameTGF-beta pathway inhibitor (Talapo Therapeutics)TL-201
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTransforming growth factor beta inhibitors
TargetsTransforming growth factor beta
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMichigan State University
China Registration ClassN/A

Develop Information

Active CompaniesTalapo Therapeutics Inc
Inactive CompaniesMichigan State University
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A